{"id":26837,"date":"2025-11-28T10:03:00","date_gmt":"2025-11-28T09:03:00","guid":{"rendered":"https:\/\/www.icscyl.com\/mileon\/?p=26837"},"modified":"2025-11-26T22:04:51","modified_gmt":"2025-11-26T21:04:51","slug":"sesion-de-residentes-ferroterapia-en-la-insuficiencia-cardiaca","status":"publish","type":"post","link":"https:\/\/www.icscyl.com\/mileon\/residentes\/2025-11-28\/sesion-de-residentes-ferroterapia-en-la-insuficiencia-cardiaca\/","title":{"rendered":"Ferroterapia en la insuficiencia cardiaca"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"alignright size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2025\/11\/image-5.png\" alt=\"\" class=\"wp-image-26845\" style=\"width:185px;height:auto\" srcset=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2025\/11\/image-5.png 1024w, https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2025\/11\/image-5-300x300.png 300w, https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2025\/11\/image-5-150x150.png 150w, https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2025\/11\/image-5-768x768.png 768w, https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2025\/11\/image-5-624x624.png 624w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p>La sesi\u00f3n de residentes del pasado 27 de octubre fue presentada por el doctor Bay\u00f3n Rodr\u00edgue (R1 de Cardiolog\u00eda) y que abord\u00f3 el papel de la ferroterapia en la insuficiencia card\u00edaca. El d\u00e9ficit de hierro, presente en un 30-55% de los pacientes con IC cr\u00f3nica y hasta en un 80% en IC aguda, constituye un factor pron\u00f3stico independiente y se asocia con peor clase funcional, mayor tasa de hospitalizaciones y mayor mortalidad cardiovascular. Diversos ensayos cl\u00ednicos han evaluado la eficacia de la ferroterapia intravenosa, particularmente con carboximaltosa f\u00e9rrica, y aunque han mostrado una reducci\u00f3n significativa sobre las hospitalizaciones y una mejora en la capacidad funcional de estos pacientes, no han tenido impacto significativo sobre la mortalidad cardiovascular. Cabe destacar la menor eficacia del hierro oral, que no demostr\u00f3 mejor\u00eda significativa a nivel funcional. Su presentaci\u00f3n se encuentra disponible a continuaci\u00f3n.<\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-fd7fee15-e36e-4b37-b710-35e49fd8dae7\" href=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2025\/11\/Dr-Bayon-sesres-Oct25.pdf\">Dr Bayon sesres Oct25<\/a><a href=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2025\/11\/Dr-Bayon-sesres-Oct25.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-fd7fee15-e36e-4b37-b710-35e49fd8dae7\">Descarga<\/a><\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La sesi\u00f3n de residentes del pasado 27 de octubre fue presentada por el doctor Bay\u00f3n Rodr\u00edgue (R1 de Cardiolog\u00eda) y que abord\u00f3 el papel de la ferroterapia en la insuficiencia card\u00edaca. El d\u00e9ficit de hierro, presente en un 30-55% de los pacientes con IC cr\u00f3nica y hasta en un 80% en IC aguda, constituye un [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[721],"tags":[769],"class_list":["post-26837","post","type-post","status-publish","format-standard","hentry","category-residentes","tag-bayon"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/26837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/comments?post=26837"}],"version-history":[{"count":5,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/26837\/revisions"}],"predecessor-version":[{"id":26864,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/26837\/revisions\/26864"}],"wp:attachment":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/media?parent=26837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/categories?post=26837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/tags?post=26837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}